EUR/USD: Allowing the usage of J&J vaccines to extend euro's surge
|EUR/USD has surged above 1.20. Now, the pair needs a shot in the arm from J&J after riding on dollar weakness, Yohay Elam, an Analyst at FXStreet, reports.
EUR/USD may receive more reasons to rise
“President Joe Biden met a Congressional delegation on Monday and additional developments are likely on Tuesday. If Democrats manage to pass a corporate tax hike, it would mean less debt issuance down the road and less pressure on bonds. In turn, lower yields would weigh on the dollar.”
“The next EUR/USD moves likely depends on developments in the old continent. The European Medicines Agency (EMA) is set to publish its verdict on Johnson & Johnson's single-dose vaccine on Tuesday. After last week's suspension, there is a good chance that the regulator allows its usage, boosting Europe's vaccination campaign.”
“Another boost to the common currency may come from Germany, where the ruling CDU/CSU bloc is about to decide on who will be the party's chancellor candidate. According to reports from Berlin, the CDU's moderate leader Armin Laschet will likely remain at the helm, providing some relief to markets.”
“The daily high of 1.2075 is the immediate resistance line. It is followed by 1.2110, which was a swing high in early March.”
“Support awaits at 1.2025, a stepping stone on the way up, followed by the round 1.20 level.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.